Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Medicine|January 9, 2015
Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgeryHong Zeng, Lei-Bo Xu, Jian-Ming Wen, et al.
Carbohydrate Research|May 10, 2011
Studies on the stereoselective synthesis of a protected α-D-Gal-(1→2)-D-Glc fragmentLangqiu Chen, Shen-De Shi, Yong-Qing Liu, et al.
Anti-Cancer Drugs|May 25, 2023
Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literatureQin-Qin Liu, Xian-Huan Yu, Qi-Bin Tang, et al.
Oncology Reports|April 5, 2014
Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitroWen-Rui Wu, Rui Zhang, Xiang-De Shi, et al.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases|December 4, 2010
[Effect of aluminum on Ca²+ concentration and expression of phospholipase C and NMDA receptor α genes in hippocampus of weaning rats as well as their neural behavior through subchronic exposure]Cui-hong Jin, Sheng-wen Wu, Ping Zhou, et al.
Experimental and Therapeutic Medicine|July 15, 2015
Clinicopathological analysis of 12 patients with autoimmune pancreatitisRui Zhang, Xiang-DE Shi, Hong Zeng, et al.
World Journal of Gastroenterology|October 1, 2004
Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancerYe-Jiang Zhou, Yu-Xia Xiong, Xiao-Ting Wu, et al.
Signal Transduction and Targeted Therapy|December 17, 2019
Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathwayRui Zhang, Hao-Ming Lin, Ruth Broering, et al.
Oncotarget|September 10, 2016
Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinomaXiang-de Shi, Xian-Huan Yu, Wen-Rui Wu, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2023
Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrenceQin-Qin Liu, Xiang-de Shi, Yan-Fang Ye, et al.
Pageof 8